Atacicept in Multiple Sclerosis Extension Study, Phase II
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Relapsing Multiple Sclerosis
Related studies linked through entity extraction aliases.
CDP323 Biomarker Study
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase 2 Study of Atacicept in Subjects With Relapsing Multiple Sclerosis (ATAMS)
- Status
- TERMINATED
- Phase
- PHASE2
Transition to Rebif New Formulation
- Status
- COMPLETED
- Phase
- PHASE3
Rebif New Formulation (RNF) Quality of Life (QOL) Study
- Status
- COMPLETED
- Phase
- PHASE3